Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.

CSE:SONA - Post by User

Sona Nanotech Inc > From the New York Times - July 6th 2020

<< Previous

Bullboard Posts

Next >>

Comment by NashDaSlashon Jul 08, 2020 9:39am

88 Views

Post# 31238463

RE:RE:RE:From the New York Times - July 6th 2020

You don't know what you are talking about. Validation studies are set up by MRIGlobal, and SONA is continuing to bloster to their clinical data with in-field testing. Nothing sinister here.

<< Previous

Bullboard Posts

Next >>

New glaucoma treatment studied in a $3.4 billion market